A one-time infusion of an in vivo gene-editing treatment vs. placebo reduced the monthly rate of hereditary angioedema ...
image: Octapharma USA presented research at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting evaluating the efficacy and safety of cutaquig® (Immune Globulin Subcutaneous ...
Longitudinal study of anti-myeloma treatment patterns in a U.S. commercial population before and after approval of bortezomib (BOR). The utility and prognostic value of positron emission tomography ...
Facility-Level Disparities in Radiation Use for Limited-Stage Small Cell Lung Cancer Patient-controlled analgesia (PCA) has been considered for managing cancer pain; however, limited research has been ...
The neonatal intensive care setting offers unique challenges when attempting to standardize drug concentrations. A diverse range of patients exists within a neonatal intensive care unit (NICU), from ...
FDA Warns of Serious Risks for Syringe Pumps at Low Infusion Rates The US Food and Drug Administration (FDA) on Thursday issued a warning to healthcare providers over serious adverse events tied to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results